OppenheimerFunds’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $365K | Sell |
2,699
-1,489
| -36% | -$201K | ﹤0.01% | 1480 |
|
|
2018
Q4 | $408K | Buy |
4,188
+1,358
| +48% | +$132K | ﹤0.01% | 1451 |
|
|
2018
Q3 | $393K | Buy |
2,830
+235
| +9% | +$32.6K | ﹤0.01% | 1541 |
|
|
2018
Q2 | $322K | Buy |
2,595
+117
| +5% | +$14.5K | ﹤0.01% | 1593 |
|
|
2018
Q1 | $276K | Sell |
2,478
-102,766
| -98% | -$11.4M | ﹤0.01% | 1628 |
|
|
2017
Q4 | $12.6M | Buy |
105,244
+20,098
| +24% | +$2.4M | 0.02% | 706 |
|
|
2017
Q3 | $11.9M | Sell |
85,146
-32,315
| -28% | -$4.53M | 0.01% | 715 |
|
|
2017
Q2 | $14.3M | Buy |
117,461
+11,088
| +10% | +$1.35M | 0.02% | 661 |
|
|
2017
Q1 | $12.9M | Buy |
106,373
+258
| +0.2% | +$31.3K | 0.02% | 709 |
|
|
2016
Q4 | $13M | Buy |
106,115
+104,017
| +4,958% | +$12.7M | 0.02% | 693 |
|
|
2016
Q3 | $257K | Sell |
2,098
-87
| -4% | -$10.7K | ﹤0.01% | 1557 |
|
|
2016
Q2 | $255K | Buy |
2,185
+542
| +33% | +$63.3K | ﹤0.01% | 1529 |
|
|
2016
Q1 | $224K | Buy |
1,643
+404
| +33% | +$55.1K | ﹤0.01% | 1561 |
|
|
2015
Q4 | $237K | Buy |
+1,239
| New | +$237K | ﹤0.01% | 1608 |
|
|
2013
Q4 | – | Sell |
-67,620
| Closed | -$7.86M | – | 950 |
|
|
2013
Q3 | $7.86M | Sell |
67,620
-12,680
| -16% | -$1.47M | 0.01% | 755 |
|
|
2013
Q2 | $7.41M | Buy |
+80,300
| New | +$7.41M | 0.01% | 727 |
|